Pancreatic involvement in chronic viral hepatitis

Figure 1 Levels of serum or tissue enzymes in patients with CLD compared to those measured in age and sex-matched control subjects. ^bP<0.01 vs controls.

Figure 2 Levels of serum or tissue enzymes at each clinical stage of CH B. ^aP<0.05 vs controls.

Figure 3 Levels of serum or tissue enzymes at several stages of CH C. ^aP<0.05 vs controls.

Figure 4 Distribution of serum enzyme levels at several stages of CH B. Box plots are given with horizontal lines for the medians, upper and lower edges indicating the 25^th and 75^th percentiles, respectively, and bars represent the extremes without including outliers. _ indicates outliers and ● indicates extremities. P values indicate the correlation between the enzyme levels and the progression of liver disease (A-D). ^aP<0.05, ^bP<0.01 vs others.

Figure 5 Distribution of serum enzyme levels in several stages of CH C. Box plots are given with horizontal lines for the medians, upper and lower edges indicating the 25^th and 75^th percentiles, respectively, and bars represent the extremes without including outliers. _ indicates outliers and ● indicates extremities. P values indicate the correlation between the enzyme levels and the progression of liver disease (A-D). ^aP<0.05, ^bP<0.01 vs others.

Figure 6 Comparison of serum and tissue enzyme levels between HBV and HCV carriers (A-C).